Correlation Between Paragon 28 and Anika Therapeutics

Can any of the company-specific risk be diversified away by investing in both Paragon 28 and Anika Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Paragon 28 and Anika Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Paragon 28 and Anika Therapeutics, you can compare the effects of market volatilities on Paragon 28 and Anika Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Paragon 28 with a short position of Anika Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Paragon 28 and Anika Therapeutics.

Diversification Opportunities for Paragon 28 and Anika Therapeutics

0.44

Correlation Coefficient

Paragon 28  Anika Therapeutics

Very weak diversification

The 3 months correlation between Paragon and Anika is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Paragon 28 and Anika Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anika Therapeutics and Paragon 28 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Paragon 28 are associated (or correlated) with Anika Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anika Therapeutics has no effect on the direction of Paragon 28 i.e., Paragon 28 and Anika Therapeutics go up and down completely randomly.

Pair Corralation between Paragon 28 and Anika Therapeutics

Considering the 90-day investment horizon Paragon 28 is expected to generate 0.82 times more return on investment than Anika Therapeutics. However, Paragon 28 is 1.22 times less risky than Anika Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Anika Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  1,025  in Paragon 28 on December 28, 2024 and sell it today you would earn a total of  279.00  from holding Paragon 28 or generate 27.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Paragon 28  vs.  Anika Therapeutics

Paragon 28

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Paragon 28 are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, Paragon 28 sustained solid returns over the last few months and may actually be approaching a breakup point.

Anika Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward indicators, Anika Therapeutics is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Paragon 28 and Anika Therapeutics

The main advantage of trading using opposite Paragon 28 and Anika Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Paragon 28 position performs unexpectedly, Anika Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anika Therapeutics will offset losses from the drop in Anika Therapeutics' long position.

The idea behind Paragon 28 and Anika Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.